XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $718,100 | -12.7% | 21,500 | 0.0% | 0.15% | -18.7% |
| Q2 2023 | $822,375 | -3.0% | 21,500 | 0.0% | 0.18% | -43.3% |
| Q4 2022 | $847,745 | +9.0% | 21,500 | 0.0% | 0.32% | +68.1% |
| Q3 2022 | $778,000 | +3.2% | 21,500 | -12.2% | 0.19% | +15.8% |
| Q2 2022 | $754,000 | -2.2% | 24,500 | 0.0% | 0.16% | +24.1% |
| Q4 2021 | $771,000 | +0.1% | 24,500 | 0.0% | 0.13% | -5.0% |
| Q3 2021 | $770,000 | +69.2% | 24,500 | 0.0% | 0.14% | +59.1% |
| Q2 2021 | $455,000 | +5.3% | 24,500 | 0.0% | 0.09% | -3.3% |
| Q1 2021 | $432,000 | +15.5% | 24,500 | 0.0% | 0.09% | +7.1% |
| Q4 2020 | $374,000 | +29.9% | 24,500 | 0.0% | 0.08% | +9.0% |
| Q3 2020 | $288,000 | – | 24,500 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |